SPL 0.00% 10.5¢ starpharma holdings limited

Interim decision to amend the Poison Standard for astodrimer sodium, page-27

  1. 2,063 Posts.
    lightbulb Created with Sketch. 303
    @Starlink what sarge thinks is irrelevant to this. I'd like to know what the company thinks but to date zip.
    This leads me on to the Vivagel saga where JF announced at the 2022 AGM when questioned that the Mundipharma licence for sales and distribution was not working which was subsequently cancelled with Mundipharma compensating Starpharma for their failure to comply with the licensing terms.
    Since then some 16 months later they still haven't been able to strike a deal with a new distributor.
    Failure to strike deals has become their hallmark of late and to go further the ones they have struck in the past have been total failures.
    And to add insult to injury our obsolete Chairman has the nerve to stand up at the AGM each year to announce what a great year it's been.
    Please Rob Thomas don't insult us any longer
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.